Form DRS - Draft Registration Statement:
SEC Accession No. 0000912057-19-000303
Filing Date
2019-07-12
Accepted
2019-07-12 17:06:13
Documents
16

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1886171
2 g114644.jpg GRAPHIC 98928
3 g142480.jpg GRAPHIC 119210
4 g416205.jpg GRAPHIC 35324
5 g438810.jpg GRAPHIC 42584
6 g453739.jpg GRAPHIC 20890
7 g501588.jpg GRAPHIC 37620
8 g504981.jpg GRAPHIC 88585
9 g584941.jpg GRAPHIC 35709
10 g602177.jpg GRAPHIC 86178
11 g701865.jpg GRAPHIC 96160
12 g731568.jpg GRAPHIC 83509
13 g785591.jpg GRAPHIC 74940
14 g817326.jpg GRAPHIC 30086
15 g849095.jpg GRAPHIC 43010
16 g1043123.jpg GRAPHIC 63175
  Complete submission text file 0000912057-19-000303.txt   3203973
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-02729 | Film No.: 19953516
SIC: 2834 Pharmaceutical Preparations